OXYGENIX Trademark

Trademark Overview


On Tuesday, November 1, 2005, a trademark application was filed for OXYGENIX with the United States Patent and Trademark Office. The USPTO has given the OXYGENIX trademark a serial number of 79020507. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, November 1, 2015. This trademark is owned by Oxygenix Co., Ltd.. The OXYGENIX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of neoplasms, infectious and parasitic diseases, diseases of the blood and blood-forming organs, disorders involving the immune and endocrine systems, mental and behavioral disorders, diseases of the nervous, circulatory, respiratory, musculoskeletal, genito-urinary and digestive systems, diseases of the eye, ear, skin and subcutaneous tissue, congenital malformations, deformations and chromosomal abnormalities; anesthetics, hemotropic agents, antiseptics, hemostatics, transfusion agents, oxygen-transporting fluids, namely, blood substitutes and oxygen therapeutics for administration to living human bodies for medical purposes; blood substitutes for human use, hemoglobin solution

Pharmaceutical research and development
oxygenix

General Information


Serial Number79020507
Word MarkOXYGENIX
Filing DateTuesday, November 1, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, November 1, 2015
Registration Number3242649
Registration DateTuesday, May 15, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2007

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neoplasms, infectious and parasitic diseases, diseases of the blood and blood-forming organs, disorders involving the immune and endocrine systems, mental and behavioral disorders, diseases of the nervous, circulatory, respiratory, musculoskeletal, genito-urinary and digestive systems, diseases of the eye, ear, skin and subcutaneous tissue, congenital malformations, deformations and chromosomal abnormalities; anesthetics, hemotropic agents, antiseptics, hemostatics, transfusion agents, oxygen-transporting fluids, namely, blood substitutes and oxygen therapeutics for administration to living human bodies for medical purposes; blood substitutes for human use, hemoglobin solution
Goods and ServicesPharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 20, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 20, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxygenix Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMinatu-ku; Tokyo 1050001
JP

Party NameOxygenix Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMinatu-ku; Tokyo 1050001
JP

Party NameOxygenix Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMinatu-ku; Tokyo 1050001
JP

Trademark Events


Event DateEvent Description
Thursday, June 2, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, June 2, 2016DEATH OF INTERNATIONAL REGISTRATION
Saturday, June 20, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, February 10, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, February 10, 2015INVALIDATION PROCESSED
Wednesday, August 20, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 20, 2013CANCELLED SECTION 71
Saturday, October 4, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 1, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 26, 2007FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, October 24, 2007FINAL DISPOSITION PROCESSED
Monday, October 15, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 15, 2007REGISTERED-PRINCIPAL REGISTER
Friday, May 11, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 27, 2007PUBLISHED FOR OPPOSITION
Wednesday, February 7, 2007NOTICE OF PUBLICATION
Wednesday, January 10, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 10, 2007ASSIGNED TO LIE
Thursday, December 14, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 14, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 13, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 13, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 2, 2006REFUSAL PROCESSED BY IB
Friday, May 12, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 12, 2006REFUSAL PROCESSED BY MPU
Thursday, May 11, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 10, 2006NON-FINAL ACTION WRITTEN
Wednesday, May 10, 2006NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, May 10, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, May 9, 2006NON-FINAL ACTION WRITTEN
Thursday, May 4, 2006ASSIGNED TO EXAMINER
Friday, March 10, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, March 9, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB